A sales rise of a third in its European Formulations business coupled with growth of almost a tenth in the firm’s US counterpart operation helped Aurobindo Pharma to report group turnover that was 9.3% higher at Rs165 billion (US$2.45 billion) in the Indian firm’s financial year ended 31 March 2018.
A sales rise of a third in its European Formulations business coupled with growth of almost a tenth in the firm’s US counterpart operation helped Aurobindo Pharma to report group turnover that was 9.3% higher at Rs165 billion (US$2.45 billion) in the Indian firm’s financial year ended 31 March 2018.
European Formulations turnover was bolstered by Aurobindo’s €135 million (US$158 million) acquisition of Portuguese generics specialist Generis Farmacêutica, which was...
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
